Fig. 1From: SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomySLCO4C1 methylation and mRNA expression level in GSE76938 dataset. a Four CpG sites methylation level (beta value) of SLCO4C1 in tumour (PC) and normal tissue. b The differential gene expression in tumor and normal tissueBack to article page